The New York Times has a story on the links between the American Heart Association, which issued a statement defending the drug Vytorin, and Merck and Schering-Plough, which makes them.

What's not entirely clear from the Times story is that the AHA actually has a page on its site which integrates the "two sources of cholesterol" tagline used to sell Vytorin into an advice page for patients -- on the AHA website.

The page offers a link through to a Merck/Schering-sponsored Web site.

A clip of the page is below. Click on it to go to the AHA site.